机构

• 上海药物研究所 [19]
• 心理研究所 [2]
• 动物研究所 [1]
• 近代物理研究所 [1]

采集方式

• OAI收割 [23]

内容类型

• 期刊论文 [23]

发表日期

• 2024 [2]
• 2023 [2]
• 2022 [2]
• 2021 [1]
• 2020 [6]
• 2019 [1]
• 更多

学科主题

筛选

浏览/检索结果: 共23条，第1-10条 帮助 条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择题名升序题名降序提交时间升序提交时间降序作者升序作者降序发表日期升序发表日期降序 Ribosomal protein S3 mediates drug resistance of proteasome inhibitor: potential therapeutic application in multiple myeloma 期刊论文  OAI收割 HAEMATOLOGICA, 2024, 卷号: 109, 期号: 4, 页码: 1206-1219 作者:  Chen, Gege;  Gao, Xuejie;  Jia, Xinyan;  Wang, Yingcong;  Xu, Li   |  收藏  |  浏览/下载：25/0  |  提交时间：2024/05/07 Design and synthesis of cantharidin derivative DCZ5418 as a TRIP13 inhibitor with anti-multiple myeloma activity in vitro and in vivo 期刊论文  OAI收割 BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2024, 卷号: 98, 页码: 7 作者:  Dong, Sanfeng;  Hu, Ke;  Shi, Yulong;  Wang, Guanli;  Yu, Dandan   |  收藏  |  浏览/下载：26/0  |  提交时间：2024/02/19 Multiple myeloma  TRIP13 inhibitor  Cantharidin  DCZ5418  DCZ0415   The novel norcantharidin derivative DCZ5417 suppresses multiple myeloma progression by targeting the TRIP13-MAPK-YWHAE signaling pathway 期刊论文  OAI收割 JOURNAL OF TRANSLATIONAL MEDICINE, 2023, 卷号: 21, 期号: 1, 页码: 17 作者:  Wang, Yingcong;  Dong, Sanfeng;  Hu, Ke;  Xu, Li;  Feng, Qilin   |  收藏  |  浏览/下载：36/0  |  提交时间：2024/01/26 Norcantharidin  Derivative  DCZ5417  TRIP13  Anti-myeloma  MAPK   Aberrant activation of TRIP13-EZH2 signaling axis promotes stemness and therapy resistance in multiple myeloma 期刊论文  OAI收割 LEUKEMIA, 2023, 页码: 4 作者:  Xu, Li;  Wang, Yingcong;  Wang, Guanli;  Guo, Shushan;  Yu, Dandan   |  收藏  |  浏览/下载：40/0  |  提交时间：2023/10/17 Preclinical validation and phase I trial of 4-hydroxysalicylanilide, targeting ribonucleotide reductase mediated dNTP synthesis in multiple myeloma 期刊论文  OAI收割 Journal of Biomedical Science, 2022, 卷号: 29, 期号: 1 作者:  Xie,Yongsheng;  Wang,Yingcong;  Xu,Zhijian;  Lu,Yumeng;  Song,Dongliang   |  收藏  |  浏览/下载：46/0  |  提交时间：2022/06/15 4-Hydroxysalicylanilid  Ribonucleotide reductase  Deoxyribonucleotides  DNA damage repair  Multiple myeloma   DCZ0014, a novel compound in the therapy of diffuse large B-cell lymphoma via the B cell receptor signaling pathway 期刊论文  OAI收割 NEOPLASIA, 2022, 卷号: 24, 期号: 1, 页码: 50-61 作者:  Chang, Shuaikang;  Li, Bo;  Xie, Yongsheng;  Wang, Yingcong;  Xu, Zhijian   |  收藏  |  浏览/下载：36/0  |  提交时间：2022/06/15 Diffuse large B cell lymphoma  DCZ0014  Apoptosis  Lyn  Syk   A novel silicone derivative of natural osalmid (DCZ0858) exerts anti-multiple myeloma activity by promoting cell apoptosis and inhibiting cell cycle and mTOR signaling 期刊论文  OAI收割 AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2021, 卷号: 13, 期号: 10, 页码: 11439-11449 作者:  Bu, Wenxuan;  Li, Bo;  Feng, Lijin;  Feng, Qilin;  Hu, Ke   |  收藏  |  浏览/下载：27/0  |  提交时间：2021/12/16 Multiple myeloma  DCZ0858  mTOR  bone marrow microenvironment  cell proliferation  cell apoptosis   A novel M phase blocker, DCZ3301 enhances the sensitivity of bortezomib in resistant multiple myeloma through DNA damage and mitotic catastrophe 期刊论文  OAI收割 Journal of Experimental & Clinical Cancer Research, 2020, 卷号: 39, 期号: 1 作者:  Hu,Liangning;  Li,Bo;  Chen,Gege;  Song,Dongliang;  Xu,Zhijian   |  收藏  |  浏览/下载：52/0  |  提交时间：2020/07/01 Multiple myeloma  Drug-resistance  DNA damage response  Cell cycle   A novel phosphoramide compound, DCZ0847, displays in vitro and in vivo anti-myeloma activity, alone or in combination with bortezomib 期刊论文  OAI收割 CANCER LETTERS, 2020, 卷号: 478, 页码: 45-55 作者:  Chen, Gege;  Hu, Ke;  Sun, Haiguo;  Zhou, Jinfeng;  Song, Dongliang   |  收藏  |  浏览/下载：41/0  |  提交时间：2020/07/01 Multiple myeloma  Bone marrow microenvironment  DNA damage  JAK2/STAT3 pathway   A novel silicone derivative of natural osalmid (DCZ0858) induces apoptosis and cell cycle arrest in diffuse large B-cell lymphoma via the JAK2/STAT3 pathway 期刊论文  OAI收割 SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2020, 卷号: 5, 期号: 1, 页码: 11 作者:  Lu, Kang;  Li, Bo;  Zhang, Hui;  Xu, Zhijian;  Song, Dongliang   |  收藏  |  浏览/下载：34/0  |  提交时间：2020/07/01